What's the Problem?
Worldwide there are millions of people with undiagnosed genetic diseases. Most people do not know their risk of developing common diseases like cancer and diabetes or their food intolerances. Moreover, they receive medications that are not right for them. This scenario could change dramatically if they could have access to their DNA information and be able to share it with healthcare professionals. Today, more than ever, people are in need of personalized diagnosis, treatment and tools to prevent disease development. As sequencing prices decrease, the DNA of more and more people can be obtained and therefore genomics information promises to change the healthcare paradigm allowing precision and preventive medicine. However, the bottleneck for this to happen is the lack of a solution that can easily analyze and share genomics information to both people and healthcare professionals. Particularly, in the Latin American region there is a lack of genomic data -less than 0,1% of the population has been analyzed- and therefore provides a unique opportunity for genomics companies to emerge.
How are they Solving it?
Bitgenia has developed a potent bioinformatic platform that enables a speedy and efficient knowledge discovery and interpretation of the vast amounts of data generated by NGS technologies. The malleability built into the platform allows Bitgenia to offer customized genomic tests facilitating the delivery of genomic information to both healthcare professionals, the pharmaceutical industry and people in general.